Title: The natural history of carcinogenesis: Implications of experimental carcinogenesis in the genesis of human cancer
Abstract: Journal of Supramolecular Structure and Cellular BiochemistryVolume 17, Issue 2 p. 133-146 Invited Review The natural history of carcinogenesis: Implications of experimental carcinogenesis in the genesis of human cancer Henry C. Pitot, Henry C. Pitot McArdle Laboratory for Cancer Research, Departments of Oncology and Pathology, The Medical School, University of Wisconsin, Madison, Wisconsin 53706Search for more papers by this authorThomas Goldsworthy, Thomas Goldsworthy McArdle Laboratory for Cancer Research, Departments of Oncology and Pathology, The Medical School, University of Wisconsin, Madison, Wisconsin 53706Search for more papers by this authorSusan Moran, Susan Moran McArdle Laboratory for Cancer Research, Departments of Oncology and Pathology, The Medical School, University of Wisconsin, Madison, Wisconsin 53706Search for more papers by this author Henry C. Pitot, Henry C. Pitot McArdle Laboratory for Cancer Research, Departments of Oncology and Pathology, The Medical School, University of Wisconsin, Madison, Wisconsin 53706Search for more papers by this authorThomas Goldsworthy, Thomas Goldsworthy McArdle Laboratory for Cancer Research, Departments of Oncology and Pathology, The Medical School, University of Wisconsin, Madison, Wisconsin 53706Search for more papers by this authorSusan Moran, Susan Moran McArdle Laboratory for Cancer Research, Departments of Oncology and Pathology, The Medical School, University of Wisconsin, Madison, Wisconsin 53706Search for more papers by this author First published: 1981 https://doi.org/10.1002/jsscb.380170204Citations: 83AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rous P, Kidd JG: J Exp Med 73: 365, 1941. 2 Mottram JC: J Pathol Bacteriol 56: 181, 1944. 3 Berenblum I, Shubik P: Br J Cancer 1: 379, 1947. 4 Friedrich-Freksa H, Gössner W, Börner P: Z Krebsforsch 72: 226, 1969. 5 Farber E: Methods Cancer Res 7: 345, 1973. 6 Bannasch P, Clining O: Virchows Arch Abt A Pathol Anat 352: 157, 1971. 7 Anthony PP: Cancer Res 36: 2579, 1976. 8 Scherer E, Hoffmann M, Emmelot P, Friedrich-Freksa M: J Natl Cancer Inst 49: 93, 1972. 9 Berger BW, Hori Y: Arch Dermatol 114: 1698, 1978. 10 Johnson LD, Nickerson RJ, Easterday CL, Stuart RS, Hertig AT: Cancer 22: 901, 1968. 11 Evans AE, Gerson J, Schnaufer L: Natl Cancer Inst Monogr 44: 49, 1976. 12 Foulds L: In O Mühlbock, P Emmelot (eds): " Cellular Control Mechanisms and Cancer." Amsterdam: Elsevier, 1964, pp 242–295. 13 Boutwell RK: Progr Exp Tumor Res 4: 207, 1964. 14 Boutwell RK: Crit Rev Toxicol 2: 419, 1974. 15 Pitot HC, Sirica AE: Biochim Biophys Acta 605: 191, 1980. 16 Pitot HC: " Fundamentals of Oncology." New York: Marcel Dekker, 2nd Edition, 1981. 17 Mintz B, Illmcnsee K: Proc Natl Acad Sci USA 72: 3585, 1975. 18 King TJ, DiBerardino MA: Ann New York Acad Sci 126: 115, 1965. 19 Friend C, Scher VV, Holland JG, Sato T: Proc Natl Acad Sci USA 68: 378, 1971. 20 Sachs L: Nature 274: 535, 1978. 21 Markert CL: Cancer Res 28: 1908, 1968. 22 Finckh ES: Med J Aust 1: 438, 1974. 23 Gronow M: Chem-Biol Interact 29: 1, 1980. 24 Pilot HC, Heidelberger C: Cancer Res 23: 1694, 1963. 25 Pilot HC: Perspect Biol Med 8: 50, 1964. 26 Goldenberg DM, Pavia RA, Tsao MC: Nature 250: 649, 1974. 27 Foulds L: J Natl Cancer Inst 17: 701, 1956. 28 Cairns J: Nature 255: 197, 1975. 29 Smets LA: Biochim Biophys Acta 605: 93, 1980. 30 Sachs L: Colloq Gesellschaft Physiol Chem 17: 242, 1966. 31 Iannaccone PM, Gardner RL, Harris H: J Cell Sci 29: 249, 1978. 32 Pitot HC, Barsness L, Goldsworthy T, Kitagawa T: Nature 271: 456, 1978. 33 Pitot HC, Goldsworthy T, Moran S, Sirica AE, Weeks J: In E Hecker, NE Fusenig, F Marks (eds): " Cocarcinogenesis and Biological Effects of Tumor Promoters." New York: Raven Press (in press). 34 Pitot HC: In RW Estabrook, E Lindenlaub (eds): " The Induction of Drug Metabolism." New York: FK Schauauer-Verlag, 1979, pp 471–483. 35 Salaman MH, Roe FJC: Br J Cancer 7: 472, 1953. 36 Kitagawa T, Pitot HC, Miller EC, Miller JA: Cancer Res 39: 112, 1979. 37 Mirvish SS: Adv Cancer Res 11: 1, 1968. 38 Kitagawa T, Harakawa T, Ishikawa T, Neomoto N, Takayama S: Toxicol Lett 6: 167, 1980. 39 Tsuda H, Lee G, Farber E: Cancer Res 40: 1157, 1980. 40 Borek C, Sachs L: Nature 210: 276, 1966. 41 Kakunaga, T: Cancer Res 35: 1637, 1975. 42 Mïronescu S, Love R: Cancer Res 34: 2562, 1974. 43 Peraino C, Fry RJM, Staffeldt E, Kisieleski WE: Cancer Res 33: 2701, 1973. 44 Solt D, Farber E: Nature 263: 701, 1976. 45 Ying TS, Sarma DSR, Farber E: Proc 11th Intern Congress Biochem 1979, p 664. 46 Roe FJC, Clack J: Br J Cancer 17: 596, 1963. 47 Van Duuren BL, Smith AC, Melchionne SM: Cancer Res 38: 865, 1978. 48 Drückrey H: In R Truhaut (ed): " Potential Carcinogenic Hazards from Drugs, Evaluation of Risks, UICC Monograph Series, Vol. 7." Berlin: Springer-Verlag, 1967, pp 60–77. 49 Brown CC: Oncology 33: 62, 1976. 50 Schneiderman MA, Decouflec P, Brown CC: Ann NY Acad Sci 329: 92, 1979. 51 Verma AK, Boutwell RK: Carcinogenesis 1: 271, 1980. 52 Peraino C, Staffeldt EF, Haugen DA, Lombard LS, Stevens FJ, Fry RJM: Cancer Res 40: 3268, 1980. 53 Diamond L, O'Brien TG, Baird WM: Adv Cancer Res 32: 1, 1980. 54 Berwald Y, Sachs L: Nature 200: 1182, 1963. 55 Reznikoff CA, Brankow DW, Heidelberger C: Cancer Res 33: 3231, 1973. 56 Borek C: Radiat Res 79: 209, 1979. 57 Yotti LP, Chang CC, Trosko JE: Science 206: 1089, 1979. 58 Driedger PE, Blumberg PM: Proc Nail Acad Sci USA 77: 567, 1980. 59 Horowitz AD, Greenbaum E, Weinstein IB: Proc Natl Acad Sci USA (in press). 60 Pitot HC, Goldsworthy T, Campbell HA, Poland A: Cancer Res 40: 3616, 1980. 61 Poland A, Glover E: Mol Pharmacol 11: 389, 1975. 62 Berenbium I: J Natl Cancer Inst 60: 723, 1978. 63 Taper HS: Cancer 42: 462, 1978. 64 Medina D: Cancer Res 36: 2589, 1976. 65 Clemmenson J: Acta Pathol Microbiol Scand Suppl 261: 38, 1977. 66 Hoover RN, Strasser PH: Lancet 2: 837–840, 1980. 67 Kessler II, Clark JP: JAMA 240: 349, 1978. 68 Tannenbaum A, Silverstone H: Adv Cancer Res 1: 451, 1953. 69 Wynder EL: Cancer 43: 1955, 1979. 70 Doll R, Peto P: Br Med J 2: 1525, 1976. 71 Howe GR, Burch JD, Miller AB, Cook GM, Esteve J, Morrison B, Gordon P, Chambers LW, Fodor G, Winsor GM: J Natl Cancer Inst 64: 701, 1980. 72 Selikoff I, Hammond C, Churg J: JAMA 204: 104, 1968. 73 Nishizumi M: Gann 70: 835, 1979. 74 Cohen SM, Arai M, Jacobs JB, Friedell GH: Cancer Res 39: 1207, 1979. 75 Tuyns AJ: Cancer Res 39: 2840, 1979. 76 Weber J, Hecker E: Experientia 34: 679, 1978. 77 Kopelovich L, Bias NE, Helson L: Nature 282: 619, 1979. Citing Literature Volume17, Issue21981Pages 133-146 ReferencesRelatedInformation
Publication Year: 1981
Publication Date: 1981-01-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 117
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot